Welcome Message - Blog from AAM President and CEO Dan Leonard: Generics: The Bridge to A Vaccine.

Plan to Secure Our Medicines

The U.S. generics and biosimilars industry, makers of 90% of our nation's prescription medicines, has a plan to #SecureOurMeds. We already produce billions of doses domestically and our plan ensures continued patient access through COVID and beyond.
Watch Video
You Are Invited to GRx+Biosims 2020

Christine Simmon, AAM SVP Policy and Executive Director of the Biosimilars Council, invites a global audience to join GRx+Biosims 2020 on November 9-11, 2020. Take a deep dive into the policy & regulatory challenges facing the U.S. biosimilars market.
Watch Video
Connect With Industry Experts

Looking to be inspired? Join us for the GRx+Biosims 2020 virtual conference on November 9-11, 2020. Attending the GRx+Biosims conference has never been easier or less expensive.

Learn More
Securing the U.S. Rx Supply Chain

The generic drug industry in the U.S. can expand domestically to increase national security, lessen dependence on any single country and create more jobs. Learn about our plan.

View Blueprint
Industry Response to COVID-19

The coronavirus (COVID-19) pandemic is disrupting everyday life around the world and imposing unprecedented stress on our health care system. Here are some responses and resources from the U.S. generics and biosimilars industry.

Learn More

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Policy

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

Henry Waxman, Chairman, Waxman Strategies

Sep 24, 2020 | Bob Billings

Thank you, Rep. Henry Waxman

Apotex

Sep 18, 2020 | Jewel Smith

Member Spotlight: Apotex

Sep 16, 2020 | Erica Klinger

How to Talk About High Drug Costs in a Time of Economic Insecurity

Video

Sep 10, 2020 | Erica Klinger

Christine Simmon: Policy and Biosimilars Sessions at the GRx+Biosims 2020 Virtual Conference

Dan Leonard AAM Welcome Message

Sep 9, 2020 | Dan Leonard

Generics: The Bridge to A Vaccine

Dan Leonard Named AAM CEO

Aug 25, 2020 | Rachel Schwartz

Association for Accessible Medicines Names New President and CEO